OVA (257-264), amide is the SIINFEKL epitope presented in C-terminally amidated form for stability and conformational tuning. Its sequence supports high-affinity MHC binding while allowing investigation of terminal-charge effects. Researchers employ it to compare epitope behavior with free-acid counterparts. The peptide aids refined modeling of OVA peptide presentation.
CAT No: O05012
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
2. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More